Suppr超能文献

1987 - 1996年儿童肾移植:北美儿科肾移植协作研究1996年年报

Renal transplantation in children from 1987-1996: the 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.

作者信息

Feld L G, Stablein D, Fivush B, Harmon W, Tejani A

机构信息

Department of Pediatrics, Atlanta Health System, Florham Park, New Jersey, USA.

出版信息

Pediatr Transplant. 1997 Nov;1(2):146-62.

Abstract

The 1996 Annual Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) summarizes data voluntarily collected from 130 centers on 4329 children and adolescent patients who received renal transplants on or after January 1, 1987. This report updates information on transplants; data on dialysis and chronic renal insufficiency have, for the first time, been reported separately (in submission). The NAPRTCS registry shows that the majority of pediatric renal transplants are performed in children above 6 years of age (73%). The most frequent diagnoses include obstructive uropathy (16%), aplastic/hypoplastic/dysplastic kidneys (16%), and focal segmental glomerulosclerosis (12%). Pre-emptive transplantation was performed in 24% of patients. Triple drug maintenance therapy with prednisone, cyclosporine and azathioprine was used by >70% of all transplant recipients throughout 7 years of follow-up. Fifty-six per cent of transplant recipients were rehospitalized during months 1-5 (51% live donor (LD), 62% cadaver donor (CD)), with rejection and infection as the main causes. In the period 30-35 months post-transplant, 19-22% of patients (163 LD, 185 CD) were rehospitalized. The median time to the first rejection was 46 days for CD transplants and 377 days for LD grafts (p<.001). Six-year graft survival rates were 73% and 56% for LD grafts and CD grafts, respectively (p<.001). The overall growth deficit was constant over a period of 60 months. However, children transplanted under 5 years of age reduce their height deficit by about one-third compared to an increase in height deficit of up to 22% for older children. The NAPRTCS data analysis also demonstrates a delay in first rejection episodes in LD compared to CD transplants, and a steady improvement in CD graft survival over the past 5 years in pediatric transplant recipients.

摘要

北美儿科肾移植协作研究(NAPRTCS)1996年年报总结了自1987年1月1日及以后接受肾移植的4329名儿童和青少年患者的数据,这些数据由130个中心自愿提供。本报告更新了移植相关信息;透析和慢性肾功能不全的数据首次单独报告(正在提交)。NAPRTCS登记处显示,大多数儿科肾移植手术是在6岁以上儿童中进行的(73%)。最常见的诊断包括梗阻性尿路病(16%)、发育不全/发育不良/发育异常肾(16%)和局灶节段性肾小球硬化(12%)。24%的患者接受了择期移植。在整个7年的随访中,超过70%的移植受者使用泼尼松、环孢素和硫唑嘌呤进行三联药物维持治疗。56%的移植受者在第1至5个月再次住院(活体供肾者(LD)为51%,尸体供肾者(CD)为62%),主要原因是排斥反应和感染。在移植后30至35个月期间,19%至22%的患者(163例LD,185例CD)再次住院。尸体供肾移植首次排斥反应的中位时间为46天,活体供肾移植为377天(p<0.001)。活体供肾移植和尸体供肾移植的6年移植存活率分别为73%和56%(p<0.001)。在60个月的时间里,总体生长发育迟缓情况保持不变。然而,与年龄较大儿童身高差距增加高达22%相比,5岁以下接受移植的儿童身高差距减少了约三分之一。NAPRTCS的数据分析还表明,与尸体供肾移植相比,活体供肾移植首次排斥反应发作有所延迟,并且在过去5年中儿科移植受者尸体供肾移植的存活率稳步提高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验